Suzhou, China

Shan Gao

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 25(Granted Patents)


Location History:

  • Kunshan, CN (2016 - 2024)
  • Suzhou, CN (2022 - 2024)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Shan Gao**

Introduction

Shan Gao is a renowned inventor based in Suzhou, China, recognized for his significant contributions to the field of molecular biology. With a portfolio of ten patents, Gao has focused his innovative efforts on developing nucleic acid technologies aimed at combating various health issues, particularly those related to viral infections. His work continues to influence the advancement of pharmaceutical compositions and therapeutic strategies.

Latest Patents

Among his latest patents, Shan Gao has developed a siRNA aimed at inhibiting the expression of the apolipoprotein C3 (ApoC3) gene. This invention includes a novel pharmaceutical composition and conjugate that leverages modified nucleotides to enhance therapeutic efficacy. Additionally, he has contributed to a siRNA formulation targeting the hepatitis B virus, again incorporating modified nucleotides in its design. Each of these formulations consists of both a sense strand and an antisense strand, designed with specific nucleotide sequences to ensure optimal performance with minimal variations from established sequences.

Career Highlights

Shan Gao is currently employed at Suzhou Ribo Life Science Company, Ltd., where he collaborates with a team of skilled professionals dedicated to pioneering advancements in life sciences. His work has played a pivotal role in progressing the understanding and treatment of genetic expression related to various diseases, showcasing his commitment to innovation in health solutions.

Collaborations

Shan Gao works alongside esteemed colleagues such as Hongyan Zhang and Daiwu Kang, contributing to the development of breakthrough technologies in molecular therapeutics. Their collective efforts have enabled significant strides in the sphere of RNA interference and its applications in medicine.

Conclusion

With a robust portfolio of patents and innovative contributions to the field of molecular biology, Shan Gao stands as a prominent figure in the realm of scientific research and development. His ongoing work at Suzhou Ribo Life Science Company, Ltd. continues to pave the way for new treatments and therapeutic strategies, making a lasting impact on healthcare and medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…